The changes in angiogenic gene expression in recurrent multiple chorioangiomas

Fetal Diagn Ther. 2007;22(3):161-8. doi: 10.1159/000098708. Epub 2006 Jan 17.

Abstract

Objectives: To assess the messenger ribonucleic acid expression in placental tissue of growth factors, cytokines, angiogenic and anti-angiogenic factors in one case of recurrent multiple chorioangiomas.

Methods: Complementary deoxyribonucleic acid array analysis was performed on the affected placentae and on normal placentaes (controls) to compare messenger ribonucleic acid levels of 96 genes involved in angiogenesis.

Results: Eleven genes presented more than two-fold alteration in expression levels: undetectable (angiopoietin 1, osteonectin, tyrosine kinase endothelial, neuropilin 1), decreased (transcription growth factor beta receptor 3, tissue inhibitor of metalloproteinase type 2, EGF receptor, integrin-alpha V, tyrosine kinase vascular endothelial growth factor receptor 2), increased (angiopoietin 2, osteopontin).

Conclusions: We illustrated the complexity of angiogenic disruption in recurrent multiple chorioangiomas leading to the difficulty to propose a single candidate gene to explain this pathology.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Gene Expression Profiling
  • Hemangioma / complications
  • Hemangioma / genetics*
  • Hemangioma / pathology
  • Humans
  • Infant, Newborn
  • Male
  • Neovascularization, Pathologic / genetics*
  • Oligonucleotide Array Sequence Analysis
  • Placenta Diseases / genetics*
  • Placenta Diseases / pathology
  • Pregnancy
  • Pregnancy Complications, Neoplastic / genetics
  • Pregnancy Complications, Neoplastic / pathology
  • Recurrence